A Virtual Breakfast Chat with Gene Therapy Pioneer Kathy High

Description

Johns Hopkins Technology Ventures (JHTV) hosts gene therapy pioneer Kathy High, emeritus professor of pediatrics at the Perelman School of Medicine at the University of Pennsylvania. She will discuss her story of a clinician researcher whose accomplishments in basic, translational, and clinical investigation include the founding of Spark Therapeutics, the $4.8-billion company behind Luxturna, the first gene therapy for genetic disease to obtain regulatory approval in the U.S. and Europe.

In conversation with JHTV's Christy Wyskiel, High will reflect on academic-industry collaborations, academic venture creation, and the future of gene therapy.